Showing 3051-3060 of 3315 results for "".
- Staar Surgical Announces Strategic Alliance Agreement with California Center for Refractive Surgery (CCRS)https://modernod.com/news/staar-surgical-announces-strategic-alliance-agreement-with-california-center-for-refractive-surgery-ccrs/2477178/Staar Surgical announced it has entered into a strategic alliance with the California Center for Refractive Surgery (CCRS), a Los Angeles based eye care group with locations in Hancock Park and Sherman Oaks. “Our new multi-clinic alliance with CCRS and its founder Dr. Paul Lee is represent
- GenSight Biologics Reports Findings From Studies Highlighting Benefits From Lumevoq Compared to LHON Natural Historyhttps://modernod.com/news/gensight-biologics-reports-findings-from-studies-highlighting-benefits-from-lumevoq-compared-to-lhon-natural-history/2477163/GenSight Biologics reported results from the REALITY registry study and an analysis of REVERSE and RESCUE phase 3 data, which further highlight the poor prognosis for patients with loss of vision due to Leber Hereditary Optic Neuropathy (LHON) associated with the ND4 mutation. The results
- Staar Surgical Announces FDA IDE Clinical Study Approvalhttps://modernod.com/news/staar-surgical-announces-fda-ide-clinical-study-approval-2/2477164/Staar Surgical announced that the FDA, in a letter dated December 6, 2019, stated that it has determined that Staar has provided sufficient data to support initiation of a human clinical study in the United States of the EVO/EVO+ VISIAN Implantable Collamer Lens for Myopia, and EVO/EVO+ VISIAN To
- Watching for Radiation Harm After Interventional Procedureshttps://modernod.com/news/watching-for-radiation-harm-after-interventional-procedures/2477165/Interventional procedures can expose interventionalists and nearby staff to high doses of radiation, and this can lead to radiation-associated lens opacities, said Madan Rehani, PhD, director of Global Outreach for Radiation Protection at Massachusetts General Hospital in Boston, in a Medscape
- Sight Sciences Appoints Erica Rogers to its Board of Directorshttps://modernod.com/news/sight-sciences-appoints-erica-rogers-to-its-board-of-directors/2477149/Sight Sciences announced the appointment of Erica Rogers to the company’s board of directors. Ms. Rogers, President and CEO of Silk Road Medical, is an experienced leader and entrepreneur in the medical device industry. She most recently led Silk Road Medical through FDA approval of
- Korean Ophthalmologist Oh Jungwoo Performs “25 Sec LASEK” in Public for the First Timehttps://modernod.com/news/korean-ophthalmologist-oh-jungwoo-performs-25-sec-lasek-in-public-for-the-first-time/2477147/Dr. Oh Jungwoo from Eos Eye Center in Gangnam-gu, Korea, revealed a “25 sec LASEK” surgery publicly by video. This is the first time the operation has been released to the public and it shows Dr. Oh’s surgery on a patient’s left eye with minimal corneal damage in 25 second
- New Consensus Recommendations Guide Sjogren’s Syndrome Managementhttps://modernod.com/news/new-consensus-recommendations-guide-sjogrens-syndrome-management/2477140/New consensus-based recommendations from the European League Against Rheumatism (EULAR) address the management of Sjogren’s syndrome with topical and systemic therapies, according to a Reuters report. Sjogren’s syndrome
- Acuity Eyecare Group Announces Rebranding and New Corporate Namehttps://modernod.com/news/acuity-eyecare-group-announces-rebranding-and-new-corporate-name/2477131/Acuity Eyecare Group, which operates leading eyecare groups across the U.S. and has backing by private equity group Riata Capital, is announcing a new name, AEG Vision, along with other corporate updates, according to a
- Air Pollution Linked to Higher Glaucoma Riskhttps://modernod.com/news/air-pollution-linked-to-higher-glaucoma-risk/2477124/People in neighborhoods with higher amounts of fine particulate matter pollution were at least 6% more likely to report having glaucoma than those in the least-polluted areas, according to the findings published in Investigative Ophthalmology & Visual Science. “We have found yet
- Iveric bio Appoints Guangping Gao, PhD, Internationally Recognized Gene Therapy Pioneer as Chief Strategist, Gene Therapyhttps://modernod.com/news/iveric-bio-appoints-guangping-gao-phd-internationally-recognized-gene-therapy-pioneer-as-chief-strategist-gene-therapy/2477122/Iveric bio announced the appointment of Guangping Gao, PhD, as Chief Strategist, Gene Therapy. Dr. Gao brings more than 30 years of scientific research experience in gene-based treatments. As one of the world’s leading gene therapy experts, Dr. Gao’s highly distinguished career includes major con